These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 15772917

  • 1. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A.
    J Nephrol; 2005; 18(1):5-8. PubMed ID: 15772917
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Nov; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 4. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells.
    Nielsen PK, Feldt-Rasmussen U, Olgaard K.
    Nephrol Dial Transplant; 1996 Sep; 11(9):1762-8. PubMed ID: 8918619
    [Abstract] [Full Text] [Related]

  • 5. 1,25-Dihydroxyvitamin D downregulation of TGFalpha/EGFR expression and growth signaling: a mechanism for the antiproliferative actions of the sterol in parathyroid hyperplasia of renal failure.
    Dusso A, Cozzolino M, Lu Y, Sato T, Slatopolsky E.
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):507-11. PubMed ID: 15225829
    [Abstract] [Full Text] [Related]

  • 6. [The mechanisms of parathyroid hyperplasia and its regression].
    Tokumoto M, Taniguchi M.
    Clin Calcium; 2007 May; 17(5):665-76. PubMed ID: 17470994
    [Abstract] [Full Text] [Related]

  • 7. Calcitriol pulse therapy and histology of parathyroid glands in hemodialysis patients.
    Lomonte C, Martino R, Selvaggiolo M, Bona RM, Cazzato F, Milano R, Chiarulli G, Basile C.
    J Nephrol; 2003 May; 16(5):716-20. PubMed ID: 14733419
    [Abstract] [Full Text] [Related]

  • 8. Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors.
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S27-34. PubMed ID: 16109139
    [Abstract] [Full Text] [Related]

  • 9. Calcium-sensing receptor expression and parathyroid hormone secretion in hyperplastic parathyroid glands from humans.
    Cañadillas S, Canalejo A, Santamaría R, Rodríguez ME, Estepa JC, Martín-Malo A, Bravo J, Ramos B, Aguilera-Tejero E, Rodríguez M, Almadén Y.
    J Am Soc Nephrol; 2005 Jul; 16(7):2190-7. PubMed ID: 15888568
    [Abstract] [Full Text] [Related]

  • 10. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor].
    Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():206-16. PubMed ID: 16279026
    [No Abstract] [Full Text] [Related]

  • 11. The genetic background of uremic secondary hyperparathyroidism.
    Aucella F, Morrone L, Stallone C, Gesualdo L.
    J Nephrol; 2005 Sep; 18(5):537-47. PubMed ID: 16299679
    [Abstract] [Full Text] [Related]

  • 12. [Effects of intermittent treatment with sevelamer hydrochloride on parathyroid hyperplasia and vascular calcification in rats with chronic kidney disease].
    Nagano N, Miyata S, Abe M, Wakita S, Kobayashi N, Wada M.
    Clin Calcium; 2005 Sep; 15 Suppl 1():35-9; discussion 39-40. PubMed ID: 16272627
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of secondary hyperparathyroidism.
    Silver J, Kilav R, Naveh-Many T.
    Am J Physiol Renal Physiol; 2002 Sep; 283(3):F367-76. PubMed ID: 12167586
    [Abstract] [Full Text] [Related]

  • 14. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D.
    Naveh-Many T, Rahamimov R, Livni N, Silver J.
    J Clin Invest; 1995 Oct; 96(4):1786-93. PubMed ID: 7560070
    [Abstract] [Full Text] [Related]

  • 15. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats.
    Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T.
    Nephrol Dial Transplant; 2008 May; 23(5):1529-36. PubMed ID: 18156462
    [Abstract] [Full Text] [Related]

  • 16. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia.
    Basile C, Lomonte C, Vernaglione L, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Cazzato F.
    Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747
    [Abstract] [Full Text] [Related]

  • 17. New therapies for uremic secondary hyperparathyroidism.
    Torres PU, Prié D, Beck L, Friedlander G.
    J Ren Nutr; 2006 Apr; 16(2):87-99. PubMed ID: 16567265
    [Abstract] [Full Text] [Related]

  • 18. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ, Slatopolsky E.
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D treatment in chronic kidney disease.
    Andress DL.
    Semin Dial; 2005 Feb; 18(4):315-21. PubMed ID: 16076355
    [Abstract] [Full Text] [Related]

  • 20. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H, Kinugasa E.
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.